[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100482591":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":36,"centralContacts":40,"locations":46,"responsibleParty":64,"collaborators":10,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":10,"eligibilityCriteria":72,"healthyVolunteers":68,"sex":73,"minAge":10,"maxAge":10,"enrollmentInfo":74,"targetDuration":10,"studyType":77,"phases":10,"briefSummary":78,"conditions":79,"keywords":10,"overallStatus":49,"whyStopped":10,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Children's Oncology Group","NETWORK",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Ancillary-Correlative",null,"Children and adolescents with a germ cell tumor, previously enrolled on APEC14B1 or AEPI10N1 who allow access to medical records (including audiograms), grant permission to: evaluate of all of their DNA, place their genetic and health information in scientific databanks, and collect a blood sample at a routine clinic\u002Fhome visit, as well as complete a questionnaire about your health and quality of life since treatment.",[13,14,15,16],"Other: Questionnaire Administration","Other: Tumor Specimen Collection","Other: Germline DNA Samples","Procedure: Blood Sample Collection",[18,23,27,31],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":10},"OTHER","Questionnaire Administration","Questionnaire provide to participant's about their health and quality of life since treatment",[9],{"type":19,"name":24,"description":25,"armGroupLabels":26,"otherNames":10},"Tumor Specimen Collection","Tumor DNA requested from the Biopathology Center",[9],{"type":19,"name":28,"description":29,"armGroupLabels":30,"otherNames":10},"Germline DNA Samples","Germline DNA specimens requested from the Biopathology Center or newly collected saliva",[9],{"type":32,"name":33,"description":34,"armGroupLabels":35,"otherNames":10},"PROCEDURE","Blood Sample Collection","Collection and storing of serum\u002Fplasma",[9],[37],{"name":38,"affiliation":5,"role":39},"Jenny Poynter, PhD","PRINCIPAL_INVESTIGATOR",[41],{"name":42,"role":43,"phone":44,"phoneExt":10,"email":45},"Jenny Poynter","CONTACT","(612) 625-4232","poynt006@umn.edu",[47],{"facility":48,"status":49,"city":50,"state":51,"zip":52,"country":53,"countryCode":54,"cosmosGeoPoint":55,"geoPoint":60,"contacts":61},"University of Minnesota","RECRUITING","Minneapolis","Minnesota","55455","United States","US",{"type":56,"coordinates":57},"Point",[58,59],-93.26384,44.97997,{"lat":59,"lon":58},[62],{"name":38,"role":43,"phone":63,"phoneExt":10,"email":45},"612-625-4232",{"type":65,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100482591","molecular-epidemiology-of-pediatric-germ-cell-tumors-100482591",false,"NCT05564026","Molecular Epidemiology of Pediatric Germ Cell Tumors","Pediatric Germ Cell Tumors: Outcomes, Genomics and Epigenetics","Inclusion Criteria:\n\n* Cases will be eligible for the study if they have a primary diagnosis of GCT including germinoma (ICCC code105 9060-9065), teratoma (9080-9084), embryonal carcinoma (9070-9072), yolk sac tumor (9071), choriocarcinoma (9100, 9103, 9104), and mixed GCT (9085, 9101, 9102, 9105) in all sites including the brain.\n* The patient must be enrolled on APEC14B1 with consent to future contact or enrolled in AEPI10N1 with consent for future contact (N=827). Patients enrolled in AEPI10N1 were recruited from ACCRN07. All patients must be registered with COG by a North American member institution. Note: (history of) treatment on a COG therapeutic trial is not required.\n* Patients must be diagnosed at \\\u003C 20 years of age at the time of GCT diagnosis. Study participants will be followed over time in the survivorship study so there is no maximum age for participation.\n* Participants must be able to complete study related documents in English or Spanish.\n* All patients and\u002For their parents or legal guardians must provide informed consent. Assent will be obtained for participants between the ages of 8-17 years.\n* All institutional, FDA, and NCI requirements for human studies must be met.\n\nExclusion Criteria:\n\n* Participants from AEPI10N1 who did not consent to future contact. Patients who do not meet the eligibility criteria described above or cannot complete study materials in English or Spanish","ALL",{"count":75,"type":76},1151,"ESTIMATED","OBSERVATIONAL","A Non-Therapeutic Study that aims to establish a cohort of GCT survivors to understand short term and long-term adverse effects of treatment and to conduct molecular analyses to improve risk stratification.",[80,81,82,83,84,85,86,87,88],"Germ Cell Tumor","Germinoma","Teratoma","Embryonal Carcinoma","Yolk Sac Tumor","Choriocarcinoma","Mixed Germ Cell Tumor","Late Effects","Pediatric Germ Cell Tumor","2025-10-23",{"date":91,"type":92},"2025-10-24","ACTUAL",{"date":94,"type":92},"2023-04-12",{"date":96,"type":76},"2027-06-30",{"name":5,"class":6},1]